Review
HNE-modified proteins in Down syndrome: Involvement in development of Alzheimer disease neuropathology
Fecha
2017Registro en:
111, , 262-269
08915849
Autor
Barone E.
Head E.
Butterfield D.A.
Perluigi M.
Institución
Materias
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Role of Tau Protein in Neuronal Damage in Alzheimer's Disease and Down Syndrome
Cárdenas, Ana María; Ardiles, Álvaro O.; Barraza, Natalia; Báez Matus, Ximena; Caviedes, Pablo (Elsevier, 2012)Neurodegenerative disorders constitute a growing concern worldwide. Their incidence has increased steadily, in particular among the elderly, a high-risk population that is becoming an important segment of society. ... -
Down syndrome and Alzheimer's disease: common molecular traits beyond the amyloid precursor protein
Gómez, Wileidy; Morales, Rodrigo; Maracaja Coutinho, Vinicius; Parra Ortiz, Valentina; Nassif, Melissa (Impact Journals LLC, 2020)Alzheimer’s disease (AD) is the most prevalent type of dementia. Down syndrome (DS) is the leading genetic risk factor for Early-Onset AD, prematurely presenting the classic pathological features of the brain with AD. ... -
Early and Selective Activation and Subsequent Alterations to the Unfolded Protein Response in Down Syndrome Mouse Models
Lanzillotta C.; Tramutola A.; Meier S.; Schmitt F.; Barone E.; Perluigi M.; Di Domenico F.; Abisambra J.F. (IOS Press, 2018)